translated from Spanish: these drugs don’t kill the virus

Authorities of the Ministry of Health reiterated on Wednesday, during the daily conference on coronavirus, that there is no medicine to cure COVID-19 and insisted that the population should not self-medicate, but should be aware of symptoms of whether these worsen to go to a hospital to receive respiratory therapy in a timely manner.
Among the drugs and products that the authorities recommended not to use as treatments are from Oseltamivir and Ivermectin to the Transfer Factor and Citrus Nanomolecules, the same as the Secretary of the Interior, Olga Sánchez Cordero, has said that she uses to protect heding from COVID and from which she promised to share Arturo Herrera, secretary of finance to improve.
“Treatments for this disease have been used in all areas without robust scientific evidence that they are effective and not considered to cause harm,” said Simon Kawa Karasik, Director General of Coordination at the National Institutes of Health and a member of the federal government’s scientific team on infectious disease and public health issues.
Read: Health reports 579 more deaths for COVID-19; 36,000 deaths and 317,000 cases
All treatments, he added, should go through an evaluation that considers the benefits and risks of the intervention. “It’s about more benefits on the balance sheet, if we don’t have evidence of this then there’s no medical or ethical justification for using them.”
And it is not enough, he emphasized, to consider any kind of evidence to make the decision to use a drug against a disease, not enough, for example, the media notes, nor case studies. “Clinical studies and a systematic review published in scientific journals and subject to peer reviews (international scientists) are required,” he explained.
So far, Kawa Karasik said, there is no strong scientific evidence of weight to recommend any specific pharmacological treatment for COVID-19. “For severe and critical cases, only ventilatory and hemodynamic support can be recommended.”
The evidence that exists, in fact, is about treatments but not against the virus, but to help in this medium.
“Doctors, he emphasized, we have a duty to guide the patient to recognize the symptoms and know what to do and where to go if their case starts to get complicated. Patients should be questioned about pathological history and the use of everyday drugs and stress the importance of following their treatments for the control of chronic diseases such as diabetes and hypertension, which are risk factors for aggravating COVID-19.”
At this point, he explained that there is a long list of treatments that have come out in different parts and are not recommended for use, “they do not serve” in outpatients or hospitalized patients, as well as to prevent the disease. “These products even have the potential to cause damage and adverse effects and should not be administered,” Kawa Karasik said.
These include: Arbidol, Oseltamivir, Ivermectin, Azithromycin, Nitazoxanide, Transfer Factor, Colchicine, Antioxidants, Citrus Nanomolecules, Chlorine Dioxide, Intravenous Immunoglobulin and Interferons.
There are other pharmacological treatments from which scientific evidence continues to be generated, he clarified, that have the potential to generate some benefit, but there is still no robust evidence to recommend them against COVID. “Trials continue in severe patients to assess effectiveness and safety, they are under investigation, before they can be pre-prescribed.”
This list includes: Remdesivir, Favipiravir, Lopinavir/Ritonavir, Chloroquine and Hydroxychloroquine, Baricitinib (combined with Remdesivir), Tocilizumab, Sarilumab, Anakinra and Convalenciente Plasma.
There is also some treatments available with evidence of benefits for inpatients and under specific conditions, such as Dexamethasone, which has been shown to be low-dose, in patients requiring supplemental oxygen, may have some benefit, and the same anticoagulants that may contribute to the treatment of inpatients, but in outpatients their use is not indicated.
Kawa Karasik noted that the use of drugs outside of this should be reported to the authorities, “because there are drugs with clear indications for other pathologies and that are being prescribed for patients with COVID and that is totally out of the norm, it will not help us generate the scientific evidence we need and put patients at risk.”
Instead of taking drugs that don’t work and aren’t endorsed, Alethse de la Torre Rosas, director general of the National Center for HIV and AIDS Prevention and Control and alsoAs a member of the federal government’s scientific team on infectious and health issues, he recommended that the population continue to take the drugs to control chronic diseases.
He also advised having a healthy diet, exercising, drinking water, and in case of having symptoms of respiratory disease be aware that respiratory diseases do not get worse, if so, “you must go immediately to a hospital because the ventilatory support on time can make the difference between living or dying for Covid,” he said.
What we do in Animal Político requires professional journalists, teamwork, dialogue with readers and something very important: independence. You can help us keep going. Be part of the team.
Subscribe to Animal Politics, receive benefits and support free journalism #YoSoyAnimal.

Original source in Spanish

Related Posts

Add Comment